IPO Analysis
Neochem Bio SME IPO Analysis: Complete Investment Guide
IpoFly Research Team
Recently
8 min read
Track this IPO: Neochem Bio SME Live GMP →
Neochem Bio SME is ongoing for subscription. This comprehensive analysis covers all aspects including GMP trends, subscription status, financial performance, and AI-powered investment rating to help you make an informed decision.
IPO Details at a Glance
| Parameter | Details |
|---|---|
| Company Name | Neochem Bio SME |
| Issue Size | ₹42.69 Cr |
| Price Band | ₹93.0 - ₹98.0 |
| Lot Size | 1200 shares |
| Issue Opens | 2 Dec 2025 |
| Issue Closes | 4 Dec 2025 |
| Listing Date | 9 Dec 2025 |
AI-Powered Investment Rating
AI Investment Rating
⛔ Avoid
- ⚠️ Below average subscription - limited investor appetite
- ⚠️ Moderate valuation - fairly priced but limited upside
- ⚠️ Limited listing gains expected (0-5%)
- ⚠️ Average financials - growth could be better
- ❌ Weak or negative GMP - high risk of listing loss
📊 Monitor subscription trends before applying
Grey Market Premium (GMP) Analysis
Current GMP
₹4 (4.08%)
GMP %
4.08%
Expected Listing
₹102
Subscription Status
Investment Recommendation
AI Investment Rating
AVOID
- ⛔ AVOID - Better opportunities available elsewhere
- Lot Size: NOT RECOMMENDED
- Bid Price: N/A
- Risk Level: HIGH
Important Dates
| Event | Date |
|---|---|
| Issue Opens | 2 Dec 2025 |
| Issue Closes | 4 Dec 2025 |
| Allotment | 5 Dec 2025 |
| Listing Date | 9 Dec 2025 |
Investment Disclaimer
This analysis is for informational purposes only. Please consult with a SEBI-registered financial advisor before making investment decisions. Past performance does not guarantee future results.
Tags:
Neochem Bio SMENSE SMEIPO AnalysisGMPInvestment Guide